טוען...
Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
OBJECTIVE: To examine the efficacy and safety of dual blockade of the renin-angiotensin-aldosterone system (RAAS) among patients with type 2 diabetic kidney disease. DATA SOURCES: We searched the major literature repositories, including the Cochrane Central Register of Controlled Trials, MEDLINE and...
שמור ב:
| הוצא לאור ב: | Chin Med J (Engl) |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4797548/ https://ncbi.nlm.nih.gov/pubmed/26712437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0366-6999.172599 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|